Sensus Healthcare, Inc. Cost of Revenue
Sensus Healthcare, Inc. (SRTS) reported Cost of Revenue of $3.60 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfRevenue · last filed 2024-11-14
- Sensus Healthcare, Inc. cost of revenue for the quarter ending 2024-09-30 was $3.60M, a 88.53% increase year-over-year.
- Sensus Healthcare, Inc. cost of revenue for the quarter ending 2024-06-30 was $3.82M, a 100.00% increase year-over-year.
- Sensus Healthcare, Inc. cost of revenue for the quarter ending 2023-09-30 was $1.91M.
- Sensus Healthcare, Inc. cost of revenue for the quarter ending 2023-06-30 was $1.91M.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month |
|---|---|---|---|
| 2024-09-30 | $3.60M 10-Q · filed 2024-11-14 | $7.42M derived: sum of 2 quarters · filed 2024-11-14 | $11.42M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $3.82M 10-Q · filed 2024-08-13 | $7.82M 10-Q · filed 2024-08-13 | |
| 2023-09-30 | $1.91M 10-Q · filed 2024-11-14 | $3.82M derived: sum of 2 quarters · filed 2024-11-14 | $5.61M 10-Q · filed 2024-11-14 |
| 2023-06-30 | $1.91M 10-Q · filed 2024-08-13 | $3.70M 10-Q · filed 2024-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B |